Ein Mann liest Wirtschaftsnachrichten (Symbolbild).
Donnerstag, 19.04.2018 14:45 von | Aufrufe: 89

Neogen names Donofrio VP of Food Safety R&D

Ein Mann liest Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

LANSING, Mich., April 19, 2018 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it had named Dr. Robert Donofrio as Vice President of Food Safety Research and Development. Donofrio had recently served as the director of this group of 75 scientists.

"Neogen's Board of Directors is pleased to elevate Dr. Donofrio to an officer status in the company in recognition of his prior accomplishments, as well as the ongoing development programs that he leads," said James Herbert, Neogen's executive chairman. "Donofrio's widespread grasp of immunology, chemistry, microbiology, and molecular biology has been an aid in his management of Neogen's multifaceted new product development." 

Donofrio joined Neogen in 2016 after having enjoyed an outstanding career with NSF International. He worked for 15 years there, starting from a laboratory bench position and advancing to its Director of Applied Research. At Neogen, Donofrio coordinates research activities in the U.S., as well as with the company's research teams in Scotland and England.

Neogen is the largest producer of diagnostic test kits used by industry and regulatory authorities for the detection of numerous contaminants in the world's food supply. These kits include tests for natural toxins, pathogens, spoilage organisms, allergens and unique proteins that are used in 114 countries around the world.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in worldwide biosecurity products, animal genomics testing, and the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals and veterinary instruments.

CONTACT:    
Steven J. Quinlan 
Neogen Vice President & CFO 
517/372-9200

 


ARIVA.DE Börsen-Geflüster

Kurse

11,40
+0,88%
Neogen Chart
Werbung

Mehr Nachrichten zur Neogen Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News

ARIVA.DE Redaktion Thumbnail
24.04.24 - ARIVA.DE Redaktion